The most commonly prescribed drugs were nutritional supplements like Iron, Folate, Calcium, Vitamins followed by Tetanus Toxoid.P. ShresthaS. BhandariShrestha P,Bhandari S.K. Pattern of drug prescribing during pregnancy in Nepalese women. Int J pharm.2013;3(4):680....
In 1961, the governor of Illinois asked the University of Illinois to consider how it might strengthen its contribution to the state's economy. The university was not averse to pl... EP Berman - Princeton University Press 被引量: 186发表: 2012年 Drug treatment during pregnancy For most ...
The knowledge of study participants regarding safe drug use during pregnancy was of mixed in terms of defined parameters. The most commonly prescribed classes of drugs in pregnant women were vitamins, followed by iron and calcium preparations.#This study helped to conclude the irrational drug ...
Avoid concomitant use in patients receiving MAOIs or within 14 days of stopping treatment with an MAOI. (7) Use In Specific Populations Pregnancy: May cause fetal harm.(8.1) Lactation: Not recommended. (8.2) See 17 for PATIENT COUNSELING INFORMATION and Medication Guide. Revised: 12/2023...
Pregnancy: Third trimester use may increase risk for symptoms of poor adaptation (respiratory distress, temperature instability, feeding difficulty, hypotonia, tremor, irritability) in the neonate (8.1) Hepatic Impairment: Avoid use in patients with chronic liver disease or cirrhosis (5.14) Renal ...
human dose of 80 mg per day, based on body surface area) or higher. There are, however, no adequate or well-controlled studies in pregnant women. Because animal reproductive studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed....
Fetal Toxicity: Limit use of NSAIDs, including naproxen and esomeprazole magnesium delayed-release tablets, between about 20 to 30 weeks in pregnancy due to the risk of oligohydramnios/fetal renal dysfunction. Avoid use of NSAIDs in women at about 30 weeks gestation and later in pregnancy due...
IN SPECIFIC POPULATIONS 8.1 Pregnancy 8.3 Nursing Mothers 8.4 Pediatric Use 8.5 Geriatric Use 8.6 Renal Impairment 8.7 Hepatic Impairment 10 OVERDOSAGE 11 DESCRIPTION 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action 12.2 Pharmacodynamics 12.3 Pharmacokinetics 13 NONCLINICAL TOXICOLOGY 13.1 Carcinogenesis, ...
Revised: 11/2024 7 DRUG INTERACTIONS 7.1 Coumarin Anticoagulants 7.2 Bile Acid Binding Resins 7.3 Immunosuppressants 7.4 Colchicine 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy 8.2 Lactation 8.4 Pediatric Use 8.5 Geriatric Use 8.6 Renal Impairment 8.7 Hepatic Impairment 10 OVERDOSAGE 11 DESCRIPTION 12 ...
There are risks associated with untreated depression in pregnancy (see Clinical Considerations). In animal reproduction studies, oral administration of mirtazapine to pregnant rats and rabbits during the period of organogenesis revealed no evidence of teratogenic effects up to 20 and 17 times the ...